654 related articles for article (PubMed ID: 22685618)
1. Mechanism of oxidative stress in neurodegeneration.
Gandhi S; Abramov AY
Oxid Med Cell Longev; 2012; 2012():428010. PubMed ID: 22685618
[TBL] [Abstract][Full Text] [Related]
2. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases.
Singh A; Kukreti R; Saso L; Kukreti S
Molecules; 2019 Apr; 24(8):. PubMed ID: 31013638
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and neurodegenerative disorders.
Li J; O W; Li W; Jiang ZG; Ghanbari HA
Int J Mol Sci; 2013 Dec; 14(12):24438-75. PubMed ID: 24351827
[TBL] [Abstract][Full Text] [Related]
4. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
Giordano S; Darley-Usmar V; Zhang J
Redox Biol; 2014; 2():82-90. PubMed ID: 24494187
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
6. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
7. How can we target oxidative stress in the treatment of neurodegenerative diseases?
Akasaka H; Ruan KH
Future Med Chem; 2016 May; 8(8):835-9. PubMed ID: 27173453
[No Abstract] [Full Text] [Related]
8. Oxidative stress and neurodegeneration: where are we now?
Halliwell B
J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
[TBL] [Abstract][Full Text] [Related]
9. Oxidative Stress and Antioxidants in Neurological Diseases: Is There Still Hope?
Carvalho AN; Firuzi O; Gama MJ; Horssen JV; Saso L
Curr Drug Targets; 2017 Mar; 18(6):705-718. PubMed ID: 27033198
[TBL] [Abstract][Full Text] [Related]
10. Natural Antioxidant Anthocyanins-A Hidden Therapeutic Candidate in Metabolic Disorders with Major Focus in Neurodegeneration.
Ullah R; Khan M; Shah SA; Saeed K; Kim MO
Nutrients; 2019 May; 11(6):. PubMed ID: 31141884
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress, antioxidants and neurodegenerative diseases.
Casetta I; Govoni V; Granieri E
Curr Pharm Des; 2005; 11(16):2033-52. PubMed ID: 15974957
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective Effect of Antioxidants in the Brain.
Lee KH; Cha M; Lee BH
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998277
[TBL] [Abstract][Full Text] [Related]
13. Targetable Pathways for Alleviating Mitochondrial Dysfunction in Neurodegeneration of Metabolic and Non-Metabolic Diseases.
Millichap LE; Damiani E; Tiano L; Hargreaves IP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768878
[TBL] [Abstract][Full Text] [Related]
14. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants.
Cui K; Luo X; Xu K; Ven Murthy MR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):771-99. PubMed ID: 15363603
[TBL] [Abstract][Full Text] [Related]
15. Glutathione in Cellular Redox Homeostasis: Association with the Excitatory Amino Acid Carrier 1 (EAAC1).
Aoyama K; Nakaki T
Molecules; 2015 May; 20(5):8742-58. PubMed ID: 26007177
[TBL] [Abstract][Full Text] [Related]
16. Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders.
Akanji MA; Rotimi DE; Elebiyo TC; Awakan OJ; Adeyemi OS
Oxid Med Cell Longev; 2021; 2021():9971885. PubMed ID: 34394839
[TBL] [Abstract][Full Text] [Related]
17. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.
Halliwell B
Drugs Aging; 2001; 18(9):685-716. PubMed ID: 11599635
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
Szeto HH
AAPS J; 2006 Aug; 8(3):E521-31. PubMed ID: 17025271
[TBL] [Abstract][Full Text] [Related]
19. Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
Lim JL; Wilhelmus MM; de Vries HE; Drukarch B; Hoozemans JJ; van Horssen J
Arch Toxicol; 2014 Oct; 88(10):1773-86. PubMed ID: 25164826
[TBL] [Abstract][Full Text] [Related]
20. Potential for therapeutic use of hydrogen sulfide in oxidative stress-induced neurodegenerative diseases.
Tabassum R; Jeong NY
Int J Med Sci; 2019; 16(10):1386-1396. PubMed ID: 31692944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
